Michelle T. Paulsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michelle T. Paulsen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ariel McShane
Cellular and Molecular Biology Program, University of Michigan Medical Sc1hool, Ann Arbor, Michigan 48109, USA
2 shared publications - Brian Magnuson
University of Michigan
2 shared publications - Ishwarya Venkata Narayanan
Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
2 shared publications - Karan Bedi
Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA
2 shared publications - Mario Ashaka
Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
2 shared publications - Mats Ljungman
University of Michigan
2 shared publications
Latest Publications
- Open Access
Characterizing nascent readthrough transcripts in human cells
Termination of transcription by RNA polymerase II (RNAPII) is critical to appropriately define transcriptome and proteome identity; yet mechanisms of termination regulation are incompletely understood. Current models suggest critical roles for the exonuclease XRN2, which is posited to “torpedo” out RNAPII after degrading uncapped and RNAPII-tethered nascent transcripts and posit an “allosteric model” wherein elongating RNAPII loses its processivity downstream of the transcription end site (TES) via unknown mechanisms. Here, we used nascent RNA Bru-seq to interrogate transcription termination across 16 human cell lines of distinct lineages, as part of the ENCODE 4 project, to identify key regulatory modes. We find that >75% of protein-coding genes engage in readthrough transcription under homeostatic conditions. Exposing human cells to oxidative stress or hyperosmotic conditions or splicing inhibitors cause an increase in readthrough transcripts globally. Using an auxin-inducible degradation approach we find that depletion of BRD4, MED14 or XRN2 increases the extent and pervasiveness of readthrough transcripts while depletion of SUPT16H results in shorter readthrough transcripts. Our study provides a comprehensive view of homeostatic readthrough transcripts in human cells and delineates key components regulating transcription termination.
Open AccessCharacterizing nascent readthrough transcripts in human cells
Termination of transcription by RNA polymerase II (RNAPII) is critical to appropriately define transcriptome and proteome identity; yet mechanisms of termination regulation are incompletely understood. Current models suggest critical roles for the exonuclease XRN2, which is posited to “torpedo” out RNAPII after degrading uncapped and RNAPII-tethered nascent transcripts and posit an “allosteric model” wherein elongating RNAPII loses its processivity downstream of the transcription end site (TES) via unknown mechanisms. Here, we used nascent RNA Bru-seq to interrogate transcription termination across 16 human cell lines of distinct lineages, as part of the ENCODE 4 project, to identify key regulatory modes. We find that >75% of protein-coding genes engage in readthrough transcription under homeostatic conditions. Exposing human cells to oxidative stress or hyperosmotic conditions or splicing inhibitors cause an increase in readthrough transcripts globally. Using an auxin-inducible degradation approach we find that depletion of BRD4, MED14 or XRN2 increases the extent and pervasiveness of readthrough transcripts while depletion of SUPT16H results in shorter readthrough transcripts. Our study provides a comprehensive view of homeostatic readthrough transcripts in human cells and delineates key components regulating transcription termination.
- 22 October 2026
- Published by Springer Nature
- Vol. 3091, 47-75
Using BruUV-Seq to Identify Enhancer RNA Expression in Live Cells
BruUV-seq is a nascent RNA sequencing technique that uses bromouridine to label RNA and UV light to suppress both transcription elongation and RNA degradation, enabling the enrichment and study of labile RNA species, such as enhancer RNAs (eRNAs), in live-cell culture models. Here, we describe both the BruUV-seq experimental method and the next-generation sequencing data analysis, which allow for the identification of eRNAs produced at active enhancer elements.
- 22 October 2026
- Published by Springer Nature
- Vol. 3091, 47-75
Using BruUV-Seq to Identify Enhancer RNA Expression in Live Cells
BruUV-seq is a nascent RNA sequencing technique that uses bromouridine to label RNA and UV light to suppress both transcription elongation and RNA degradation, enabling the enrichment and study of labile RNA species, such as enhancer RNAs (eRNAs), in live-cell culture models. Here, we describe both the BruUV-seq experimental method and the next-generation sequencing data analysis, which allow for the identification of eRNAs produced at active enhancer elements.